6978.HK Stock Analysis
69
Uncovered
Immunotech Biopharm Ltd is uncovered by Eyestock quantitative analysis.
Immunotech Biopharm Ltd. operates as an investment holding company, which through its subsidiaries engages in research and development, manufacturing and commercialization of immune cell products for treatments of cancers in the PRC. The company is headquartered in Beijing, Beijing and currently employs 267 full-time employees. The company went IPO on 2020-07-10. Its main products are EAL, CAR-T cell series and TCR-T cell series products. EAL is a multi-target cellular immunotherapy product. The company also provides cell cryopreservation services. The firm mainly conducts its businesses in the domestic market.
View Section: Eyestock Rating